EX-99.1 2 ex99-1.htm EX-99.1

 

Exhibit 99.1

 

 

Nortech Systems Reports First Quarter Results

 

MINNEAPOLIS – May 14, 2025 – Nortech Systems Incorporated (Nasdaq: NSYS) (“Nortech” or the “Company”), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical imaging, medical device, industrial and aerospace & defense markets, reported financial results for the first quarter ended March 31, 2025.

 

2025 Q1 Highlights:

 

  Net sales of $26.9 million
  Net loss of ($1.3) million, or ($0.48) per diluted share
  Adjusted earnings before interest, taxes, depreciation, and amortization (“EBITDA”) of ($1.0) million loss
  90-day backlog of $26.7 million as of March 31, 2025

 

Management Commentary

 

“Over the past few quarters, we have successfully transitioned and stabilized our business, allowing for smoother operational flow and setting a solid foundation for future growth. Nortech has taken steps to consolidate our operations to focus on driving profitability and growth within our core market segments. These strategic moves are designed to better scale the business, improve efficiency, and reduce our ongoing cost structure.” said Jay D. Miller, President and CEO. “We made tough decisions that have depressed our short-term revenues and EBITDA but have strategically positioned the Company for long-term growth and innovation specifically in the aerospace & defense and medical imaging markets.”

 

“The Company experienced delays in our defense customers’ approvals for transfers from our closed Blue Earth facility to our Bemidji plant, and those transfers continue to progress steadily. We continue to anticipate clearing the majority of this approval backlog during the second quarter of 2025. Additionally, our research and development programs, particularly in fiber optic technologies, reflect our commitment to provide customers with technologies that are lighter, faster and more sustainable. This commitment has been evident by the issuance of two new patents in the past year,” Miller added.

 

“We continue to be impressed by the dedication and collaboration demonstrated by our employees across all locations to do the hard work necessary to achieve our goals. The team’s unwavering commitment enables us to overcome challenges and embrace innovation,” Miller said.

 

“We’re also closely following changes in regulations, trade policies, and geopolitical factors for potential impacts in our key market segments. We believe the strategic repositioning of our global operations in the past year has further strengthened the Company’s ability to respond to our customers’ needs to near-shore their supply chains. We are well-prepared to shift production closer to key markets, improving efficiency and strengthening our ability to handle global challenges and uncertainties.”

 

Summary Financial Information

 

The following table provides summary financial information comparing the first quarter 2025 (“Q1 2025”) financial results to the same quarter in 2024 (“Q1 2024”).

 

($ in thousands)  Q1 2025   Q1 2024   % Change 
Net sales  $26,895   $34,215    (21.4)%
Gross profit  $3,078   $5,448    (43.5)%
Operating expenses  $4,691   $4,293    9.3%
Net (loss) income  $(1,316)  $765    (272.0)%
EBITDA  $(1,266)  $1,637    (177.3)%
Adjusted EBITDA  $(1,000)  $1,637    (161.1)%

 

 

 

 

Conference Call

 

The Company will hold a live conference call and webcast at 3:30 p.m. central time on Wednesday, May 14, to discuss the Company’s 2025 first quarter results. The call will be hosted by Jay D. Miller, Chief Executive Officer and President and Andrew D. C. LaFrence, Chief Financial Officer. To access the live audio conference call, US participants may call 888-506-0062 and international participants may call 973-528-0011. Participant Access Code: 830813. Participants may also access the call via webcast at: https://www.webcaster4.com/Webcast/Page/2814/52260.

 

###

 

About Nortech Systems Incorporated

 

Nortech Systems is a leading provider of design and manufacturing solutions for complex electromedical devices, electromechanical systems, assemblies, and components. Nortech primarily serves the medical imaging, medical device, aerospace & defense, and industrial markets. Its design services span concept development to commercial design, and include medical device, software, electrical, mechanical, and biomedical engineering. Its manufacturing and supply chain capabilities are vertically integrated around wire, cable, and interconnect assemblies, printed circuit board assemblies, as well as system-level assembly, integration, and final test. Headquartered in Maple Grove, Minn., Nortech currently has six manufacturing locations and design centers across the U.S., Latin America, and Asia. Nortech Systems is traded on the NASDAQ Stock Market under the symbol NSYS. Nortech’s website is www.nortechsys.com.

 

Forward-Looking Statements

 

This press release contains forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 including without limitation statements regarding future financial results, gaining approval of customers relating to moving production from one facility to another Company-owned facility, strengthening of customer relationships, achieving long-term strategic goals, effects of restructuring and consolidating manufacturing facilities, sustained long-term health and growth, ability to scale our business, reducing cost structure and optimism about customer pipeline. While this release is based on management’s best judgment and current expectations, actual results may differ materially from those expressed or implied and involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from the forward-looking statements include, without limitation: (1) commodity cost increases coupled with challenges in raising prices and/or customer pressure to reduce prices; (2) supply chain disruptions leading to shortages of critical components; (3) volatility in market conditions which may affect demand for the Company’s products; (4) increased competition and/or reduced demand; (5) changes in the reliability and efficiency of operating facilities or those of third parties; (6) risks related to the availability of labor; (7) the unanticipated loss of any key member of senior management; (8) geopolitical, economic, financial and business conditions; (9) the Company’s ability to steadily improve manufacturing output and product quality; (10) the impact of global health epidemics on our customers, employees, manufacturing facilities, suppliers, the capital markets and our financial condition; or (11) challenges with customers with respect to moving production from one facility to another Company-owned facility. Some of the above-mentioned factors are described in further detail in the section entitled “Risk Factors” in our annual and quarterly reports, as applicable. You should assume the information appearing in this document is accurate only as of the date hereof, or as otherwise specified, as our business, financial condition, results of operations and prospects may have changed since such date. Except as required by applicable law, including the securities laws of the United States and the rules and regulations of the United States Securities and Exchange Commission, we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, to reflect actual results or changes in factors or assumptions affecting such forward-looking statements.

 

Reconciliation of Generally Accepted Accounting Principles (“GAAP”) Measures to Non-GAAP Financial Measure

 

EBITDA is a non-GAAP financial measure used by management that we believe provides useful information to investors because it reflects ongoing performance excluding certain non-recurring items during comparable periods and facilitates comparisons between peer companies since interest, taxes, depreciation, and amortization can differ greatly between different organizations as a result of differing capital structures and tax strategies. EBITDA is defined as net income (loss) plus interest expense, plus income tax expense plus depreciation expense and amortization expense. EBITDA should be considered in addition to, not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. Adjusted EBITDA reflects the impact of restructuring and non-recurring items. EBITDA and Adjusted EBITDA are not a measurement of our financial performance under GAAP and should not be considered an alternative to net sales or net income (loss), as applicable, or any other performance measures derived in accordance with GAAP and may not be comparable to other similarly titled measures of other businesses. EBITDA and Adjusted EBITDA have limitations as an analytical metric, and you should not consider it in isolation or as a substitute for analysis of our operating results as reported under GAAP.

 

 

 

 

NORTECH SYSTEMS INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

AND COMPREHENSIVE (LOSS) INCOME

(UNAUDITED)

(IN THOUSANDS, EXCEPT SHARE DATA)

 

   THREE MONTHS ENDED 
   MARCH 31, 
   2025   2024 
         
Net sales  $26,895   $34,215 
Cost of goods sold   23,817    28,767 
Gross profit   3,078    5,448 
Operating expenses          
Selling   1,184    805 
General and administrative   2,915    3,170 
Research and development   326    318 
Restructuring charges   266    - 
Total operating expenses   4,691    4,293 
(Loss) income from operations   (1,613)   1,155 
Other expense          
Interest expense   (214)   (167)
(Loss) income before income taxes   (1,827)   988 
Income tax (benefit) expense   (511)   223 
Net (loss) income  $(1,316)  $765 
           
Net (loss) income per common share:          
Basic (in dollars per share)  $(0.48)  $0.28 
Weighted average number of common shares outstanding - basic (in shares)   2,760,929    2,742,511 
Diluted (in dollars per share)  $(0.48)  $0.26 
Weighted average number of common shares outstanding - diluted (in shares)   2,760,929    2,908,457 
           
Other comprehensive (loss) income          
Foreign currency translation   6    (183)
Comprehensive (loss) income, net of tax  $(1,310)  $582 

 

 

 

 

NORTECH SYSTEMS INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

AS OF MARCH 31, 2025 AND DECEMBER 31, 2024

(UNAUDITED)

(IN THOUSANDS, EXCEPT SHARE DATA)

 

  

MARCH 31, 2025

   DECEMBER 31, 2024 
ASSETS          
Current assets:          
Cash  $1,162   $916 
Accounts receivable, less allowances of $231 and $196, respectively   15,668    14,875 
Inventories, net   20,910    21,638 
Contract assets   13,404    13,792 
Assets held for sale   507    - 
Prepaid assets and other assets   5,673    4,094 
Total current assets   57,324    55,315 
Property and equipment, net   5,575    6,232 
Operating lease assets, net   7,831    8,139 
Deferred tax assets   2,575    2,575 
Other intangible assets, net   169    174 
Other assets   59    - 
Total assets  $73,533   $72,435 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY          
Current liabilities:          
Accounts payable  $10,062   $11,582 
Accrued payroll and commissions   2,515    1,841 
Customer deposits   5,028    5,140 
Current portion of operating leases   1,187    1,175 
Current portion of finance lease obligations   121    143 
Notes payable   563    344 
Other accrued liabilities   1,240    1,203 
Total current liabilities   20,716    21,428 
Long-term liabilities:          
Long-term line of credit   11,955    8,634 
Long-term operating lease obligations, net of current portion   7,462    7,773 
Long-term finance lease obligations, net of current portion   281    311 
Other long-term liabilities   287    284 
Total long-term liabilities   19,985    17,002 
Total liabilities   40,701    38,430 
Shareholders’ equity:          
Preferred stock, $1 par value; 1,000,000 shares authorized; 250,000 shares issued and outstanding   250    250 
Common stock - $0.01 par value; 9,000,000 shares authorized; 2,760,993 and 2,760,793 shares issued and outstanding, respectively   28    28 
Additional paid-in capital   17,466    17,329 
Accumulated other comprehensive loss   (971)   (977)
Retained earnings   16,059    17,375 
Total shareholders’ equity   32,832    34,005 
Total liabilities and shareholders’ equity  $73,533   $72,435 

 

 

 

 

NORTECH SYSTEMS INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

(IN THOUSANDS)

 

  

THREE MONTHS ENDED

MARCH 31,

 
   2025   2024 
CASH FLOWS FROM OPERATING ACTIVITIES          
Net (loss) income  $(1,316)  $765 
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:          
Depreciation   342    442 
Amortization   5    40 
Compensation on stock-based awards   118    80 
Change in accounts receivable allowances   35    (66)
Change in inventory reserves   231    76 
Other, net   -    (4)
Changes in current operating assets and liabilities:          
Accounts receivable   (814)   3,215 
Inventories   487    (1,400)
Contract assets   388    287 
Prepaid expenses and other assets   (1,588)   (328)
Accounts payable   (1,441)   (8)
Accrued payroll and commissions   674    640 
Customer deposits   (112)   (926)
Other accrued liabilities   61    15 
Net cash (used in) provided by operating activities   (2,930)   2,828 
           
CASH FLOWS FROM INVESTING ACTIVITIES          
Proceeds from sale of property and equipment   -    9 
Purchases of property and equipment   (268)   (744)
Net cash used in investing activities   (268)   (735)
           
CASH FLOWS FROM FINANCING ACTIVITIES          
Proceeds from line of credit   25,970    32,768 
Payments to line of credit   (22,710)   (32,394)
Proceeds from notes payable   219    - 
Principal payments on financing leases   (52)   (100)
Stock option exercises   19    - 
Net cash provided by financing activities   3,446    274 
           
Effect of exchange rate changes on cash   (2)   (14)
           
Net change in cash   246    2,353 
Cash - beginning of period   916    1,675 
Cash - end of period  $1,162   $4,028 

 

 

 

 

  

THREE MONTHS ENDED

MARCH 31,

 
   2025   2024 
RECONCILIATION OF NET (LOSS) INCOME TO EBITDA          
($ in thousands)          
Net (loss) income  $(1,316)  $765 
Interest   214    167 
Taxes   (511)   223 
Depreciation   342    442 
Amortization   5    40 
EBITDA   (1,266)   1,637 
Restructuring charges   266    - 
ADJUSTED EBITDA  $(1,000)  $1,637 

 

There were no material adjustments to EBITDA in the quarter ended March 31, 2024.

 

Adjustment to EBITDA in the quarter ended March 31, 2025 includes ($ in thousands):

 

  In the second quarter of 2024, we announced the closure of our Blue Earth, Minnesota facility. In connection with activities related to the Blue Earth facility and additional staff reductions in the first quarter of 2025, we incurred $266 of restructuring charges in the quarter ended March 31, 2025, which expense amount is not included in Adjusted EBITDA.

 

($ in millions)  Last Twelve Months (LTM) Ended in Quarter 
   Q1 2022   Q2 2022   Q3 2022   Q4 2022   Q1 2023   Q2 2023   Q3 2023   Q4 2023   Q1 2024   Q2 2024   Q3 2024   Q4 2024   Q1 2025 
Net Sales  $123.8   $126.1   $132.0   $134.1   $138.3   $140.8   $138.9   $139.3   $138.7   $137.5   $135.6   $128.1   $120.8 
                                                                  
Gross Profit $ - Adjusted   13.7    15.1    18.1    20.5    21.9    22.4    21.4    23.1    23.1    22.2    20.7    16.7    14.4 
Gross Margin % - Adjusted   11.0%   12.0%   13.7%   15.3%   15.8%   15.9%   15.4%   16.6%   16.6%   16.1%   14.9%   13.1%   11.9%
                                                                  
EBITDA - Adjusted  $1.9   $2.5   $4.2   $5.8   $6.7   $6.8   $6.0   $8.0   $8.1   $7.3   $5.9   $2.1   $(0.5)

 

Contact

 

Andrew D. C. LaFrence

Chief Financial Officer and Senior Vice President of Finance

[email protected]

952-345-2243